Skip to main content
Equibles
NRXS logo

NRXS · Neuraxis, INC

Track NRXS — free

Use NRXS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about NRXS

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$6.30 +0.00 (+0.00%)
Going-concern doubt — flagged Aug 11, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Neither future cash generated from operating activities, nor management's contingency plans to mitigate the risk and extend cash resources through the evaluation period, are considered probable. As a result, substantial doubt is deemed to exist about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 11, 2026
Market Cap
$79.11M
Shares
12.56M

Neuraxis, INC Earnings Call Transcripts

Every quarterly earnings call for Neuraxis, INC (NRXS) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼19.7% $646,635 −$2.12M '24 Q1 24-04-09 ▼5.3% $611,500 −$2.92M '24 Q2 24-08-09 ▲39.6% $666,625 −$1.76M '24 Q3 24-11-12 ▲21.7% $811,414 −$2.12M '25 Q3 25-11-11 ▲27.2% $968,127 −$1.71M '25 Q4 26-03-19 ▲79.5% $1.61M −$1.76M '26 Q1 26-05-12 LATEST ▲115.7% $1.93M −$2.09M '26 Q2 26-08-11
Earnings call
FY26 · Q2
2026-08-11
NeurAxis Second Quarter 2026 Results and Business Update Call
Revenue
$1.93M
▲ 115.7% YoY
Diluted EPS
$-0.19
Gross margin
85.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-12
Neuraxis, INC Q1 FY2026 Earnings Call
Positive tone Revenue growth and proof of concept Payer coverage and insurance access Category 1 CPT code and reimbursement
Revenue
$1.61M
▲ 79.5% YoY
Diluted EPS
$-0.18
Gross margin
86.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-19
NeurAxis Fourth Quarter 2025 Earnings Conference Call
Confident tone Insurance coverage / payer policy expansion PENFS / IB STEM technology and product Pediatric / children's hospital adoption
Revenue
$968,127*
▲ 27.2% YoY
Gross margin
85.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-11
Neuraxis, INC Q3 FY2025 Earnings Call
Revenue
$811,414
▲ 21.7% YoY
Diluted EPS
$-0.24
Gross margin
83.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q3
2024-11-12
Neuraxis, INC Q3 FY2024 Earnings Call
Revenue
$666,625
▲ 39.6% YoY
Diluted EPS
$-0.25
Gross margin
85.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-09
Neuraxis, INC Q2 FY2024 Earnings Call
Revenue
$611,500
▼ 5.3% YoY
Diluted EPS
$-0.42
Gross margin
88.0%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-09
Neuraxis, INC Q1 FY2024 Earnings Call
Revenue
$646,635
▼ 19.7% YoY
Diluted EPS
$-0.32
Gross margin
88.4%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–7 of 7 earnings calls
Key facts CIK 1933567 CUSIP 64134X201 13F (30d) 31 filings 31 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)